Respiratory syncytial virus (RSV) is an important human pathogen that can c
ause severe and life-threatening respiratory infections in infants and immu
nocompromised adults. We have recently shown the RSV F glycoprotein, which
mediates viral fusion and entry, interacts with the cellular protein RhoA i
n two-hybrid and in vitro binding assays. Whether this interaction occurs i
n living cells remains an open question. However, because RhoA signaling is
associated with many cellular functions relevant to RSV pathogenesis such
as actin cytoskeleton organization, expression of proinflammatory cytokines
, and smooth muscle contraction, we asked whether RhoA activation occurred
during RSV infection of HEp-2 cells. We found that the amount of isoprenyla
ted and membrane-bound RhoA in RSV-infected cultures was increased. Further
evidence of RhoA activation was demonstrated by downstream signaling activ
ity mediated by RhoA. There was an increase in p130(cas) phosphorylation du
ring RSV infection, which was prevented by Y-27632, a specific inhibitor of
Rho kinase, or lovastatin, an HMG-CoA reductase inhibitor that reduces the
synthesis of groups needed for isoprenylation. In addition, RSV infection
of HEp-2 cells resulted in an increase in the formation of actin stress fib
ers. Pretreatment of HEp-2 cells with Clostridium botulinum C3 exotoxin, an
enzyme that specifically ADP-ribosylates and inactivates RhoA, prevented R
SV-induced stress fiber formation. These observations indicate that RhoA an
d subsequent downstream signaling events are activated during RSV infection
, which has implications for RSV pathogenesis, (C) 2001 Academic Press.